search
Back to results

Dual Mobility Cups in Hip Fracture Patients (DUALITY)

Primary Purpose

Femoral Neck Fractures

Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Dual mobility cup
Standard cup
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Femoral Neck Fractures focused on measuring total hip arthroplasty, dual mobility cup, dislocation, mortality, periprosthetic joint infection, health economy

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Written informed consent
  • Diagnosis: displaced femoral neck fracture type AO 31-B2 or B3/Garden type 3 or 4
  • Eligible for THA according to local guidelines and routines

Exclusion Criteria:

  • Previous inclusion of contralateral hip
  • Delayed fracture surgery (date of injury >7 days prior to date of randomization)
  • Pathological or stress fracture of the femoral neck, or fracture adjacent to a previous ipsilateral hip implant
  • Inability or unwillingness to give written consent
  • Dementia (as diagnosed by the screening physician)
  • Unavailability of both interventions for a study subject (e.g., implants being out of stock, or lack of the individual surgeon's expertise to perform either procedure)

Sites / Locations

  • Nils HailerRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intervention

Control

Arm Description

Insertion of dual mobility cup

Insertion of standard cup

Outcomes

Primary Outcome Measures

Dislocation
Dislocation will be ascertained by identifying the occurrence of any closed or open reduction of the previously inserted THA (the "index joint") within one year after surgery.

Secondary Outcome Measures

Any re-operation of the index THA
Re-operation will be defined as the occurrence of any surgical procedure performed on the previously treated hip within one year after surgery.
Periprosthetic joint infection
Periprosthetic joint infection will be defined as the occurrence of any sign of deep infection around the previously inserted THA within one year after surgery, defined by registration of ICD or NOMESCO codes.
Patient-reported outcome
Patient-reported outcome as assessed by EQ-5D-VAS (routinely collected by the SFR at index surgery in order to obtain pre-trauma baseline, and 1 year post-operatively)
Short-term mortality
90-day mortality, as registered in the NPR
Medium-term mortality
365-day mortality, as registered in the NPR
Cost-effectiveness
Procedural costs for intervention and control treatment will be recorded at all sites, ensuring documentation of baseline costs for the two treatment alternatives. Procedural costs of admissions for closed reductions as well as for reoperations will also be collected from all units.

Full Information

First Posted
April 8, 2019
Last Updated
June 20, 2023
Sponsor
Uppsala University
Collaborators
The Swedish Research Council
search

1. Study Identification

Unique Protocol Identification Number
NCT03909815
Brief Title
Dual Mobility Cups in Hip Fracture Patients
Acronym
DUALITY
Official Title
Do Dual Mobility Cups Prevent Dislocation After Total Hip Arthroplasty Performed Due to Femoral Neck Fracture? A Registry-based, Pragmatic, Randomized Controlled Trial Comparing Dual Mobility With Standard Cups
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 17, 2020 (Actual)
Primary Completion Date
September 30, 2023 (Anticipated)
Study Completion Date
December 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Uppsala University
Collaborators
The Swedish Research Council

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Our aim is to develop a strategy that reduces the risk of dislocations after total hip arthroplasty surgery performed due to femoral neck fracture. We therefore perform a register-nested, pragmatic, randomized controlled trial to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation in the large and fragile group of elderly patients with femoral neck fractures.
Detailed Description
Total hip arthroplasty (THA) is regularly performed in patients with a femoral neck fracture. However, dislocation is very common after THA in hip fracture patients, and this complication is deleterious to health and quality of life. The dual mobility cup offers a technical solution that potentially reduces the risk of dislocation. There is however no high-level evidence to support the general use of dual mobility cups in patients with displaced femoral neck fractures, and the purpose of the proposed study is to provide evidence to support or refute the use of this concept in the very large group of hip fracture patients. We a register-nested, pragmatic randomized controlled trial (RCT) to investigate the safety and efficacy of dual mobility cups that were designed to minimize the risk of dislocation after THA. Our aim is thus to investigate whether the incidence of dislocations after THA surgery performed due to femoral neck fracture can be reduced by the use of this device. The intervention group receives a dual mobility cup (of any brand that is in general use in Sweden), and the control group receives a standard cup (of any brand that is in general use in Sweden). The choice of cup or stem fixation (cemented or uncemented), femoral head size, brand of stem type, surgical approach, antibiotic prophylaxis, and postoperative mobilization are up to the surgeon's choice and the routines that are relevant at each study site. The necessary infrastructure for this register-nested RCT is present within the Swedish Hip Arthroplasty Register (SHAR) and the Swedish Fracture Register (SFR). Pre-operative registration of fractures is already established within the SFR, and an online platform to screen, include and randomize eligible patients is established. Cross-matching of data from the SFR and the SHAR with the database of the Swedish Patient Register (SPR) is performed in order to catch endpoint not routinely collected by the SHAR. Expanded recruitment in collaboration with UK, WHITE 12-Duality, started 10/09/2022. https://www.isrctn.com/ISRCTN11895196

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Femoral Neck Fractures
Keywords
total hip arthroplasty, dual mobility cup, dislocation, mortality, periprosthetic joint infection, health economy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Insertion of dual mobility cup
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Insertion of standard cup
Intervention Type
Device
Intervention Name(s)
Dual mobility cup
Intervention Description
Patients with a displaced femoral neck fracture eligible for THA receive a dual mobility cup, as opposed to a standard cup in the control group.
Intervention Type
Device
Intervention Name(s)
Standard cup
Intervention Description
Patients with a displaced femoral neck fracture eligible for THA receive a standard cup, as opposed to a dual mobility cup in the experimental group.
Primary Outcome Measure Information:
Title
Dislocation
Description
Dislocation will be ascertained by identifying the occurrence of any closed or open reduction of the previously inserted THA (the "index joint") within one year after surgery.
Time Frame
1 year after index surgery
Secondary Outcome Measure Information:
Title
Any re-operation of the index THA
Description
Re-operation will be defined as the occurrence of any surgical procedure performed on the previously treated hip within one year after surgery.
Time Frame
1 year after index surgery
Title
Periprosthetic joint infection
Description
Periprosthetic joint infection will be defined as the occurrence of any sign of deep infection around the previously inserted THA within one year after surgery, defined by registration of ICD or NOMESCO codes.
Time Frame
1 year after index surgery
Title
Patient-reported outcome
Description
Patient-reported outcome as assessed by EQ-5D-VAS (routinely collected by the SFR at index surgery in order to obtain pre-trauma baseline, and 1 year post-operatively)
Time Frame
1 year after index surgery
Title
Short-term mortality
Description
90-day mortality, as registered in the NPR
Time Frame
90 days after index surgery
Title
Medium-term mortality
Description
365-day mortality, as registered in the NPR
Time Frame
365 days after index surgery
Title
Cost-effectiveness
Description
Procedural costs for intervention and control treatment will be recorded at all sites, ensuring documentation of baseline costs for the two treatment alternatives. Procedural costs of admissions for closed reductions as well as for reoperations will also be collected from all units.
Time Frame
1 year after index surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Written informed consent Diagnosis: displaced femoral neck fracture type AO 31-B2 or B3/Garden type 3 or 4 Eligible for THA according to local guidelines and routines Exclusion Criteria: Previous inclusion of contralateral hip Delayed fracture surgery (date of injury >7 days prior to date of randomization) Pathological or stress fracture of the femoral neck, or fracture adjacent to a previous ipsilateral hip implant Inability or unwillingness to give written consent Dementia (as diagnosed by the screening physician) Unavailability of both interventions for a study subject (e.g., implants being out of stock, or lack of the individual surgeon's expertise to perform either procedure)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nils Hailer, MD
Phone
+46186119038
Email
nils.hailer@surgsci.uu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stergios Lazarinis, MD, PhD
Organizational Affiliation
Uppsala University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Nils Hailer
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nils Hailer, MD
Phone
+46186119038
Email
nils.hailer@surgsci.uu.se
First Name & Middle Initial & Last Name & Degree
Olof Wolf, MD
Phone
+46186110000
Email
olof.wolf@akademiska.se

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32567472
Citation
Wolf O, Mukka S, Notini M, Moller M, Hailer NP; DUALITY GROUP. Study protocol: The DUALITY trial-a register-based, randomized controlled trial to investigate dual mobility cups in hip fracture patients. Acta Orthop. 2020 Oct;91(5):506-513. doi: 10.1080/17453674.2020.1780059. Epub 2020 Jun 22.
Results Reference
derived

Learn more about this trial

Dual Mobility Cups in Hip Fracture Patients

We'll reach out to this number within 24 hrs